Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.100
-0.060 (-5.17%)
Apr 25, 2025, 11:34 AM EDT - Market open

Cytosorbents Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
69505868182344
Upgrade
Market Cap Growth
-14.14%-14.14%-14.31%-62.87%-47.06%175.66%
Upgrade
Enterprise Value
96716858135272
Upgrade
Last Close Price
1.160.911.111.554.197.97
Upgrade
PS Ratio
1.771.401.861.954.228.39
Upgrade
PB Ratio
5.734.482.471.912.914.34
Upgrade
P/TBV Ratio
9.856.762.962.183.154.59
Upgrade
EV/Sales Ratio
2.701.992.181.693.126.64
Upgrade
Debt / Equity Ratio
2.422.420.780.520.220.01
Upgrade
Asset Turnover
0.710.710.540.450.480.70
Upgrade
Inventory Turnover
3.433.432.673.392.974.62
Upgrade
Quick Ratio
1.081.081.442.864.147.54
Upgrade
Current Ratio
2.202.201.813.484.708.12
Upgrade
Return on Equity (ROE)
-119.80%-119.80%-99.38%-67.00%-34.64%-18.97%
Upgrade
Return on Assets (ROA)
-20.91%-20.91%-34.37%-25.27%-15.84%-11.05%
Upgrade
Return on Capital (ROIC)
-26.30%-26.30%-41.85%-29.69%-18.15%-12.99%
Upgrade
Earnings Yield
-28.58%-41.64%-50.47%-48.51%-13.48%-2.28%
Upgrade
FCF Yield
-20.29%-29.57%-38.29%-50.74%-9.69%-1.84%
Upgrade
Buyback Yield / Dilution
-21.90%-21.90%-2.49%-0.49%-11.70%-20.35%
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q